Investigational New Drug Application Cleared by FDA; Company Expects to Initiate VAX-31 Infant Phase 2 Study by the End of January 2025 ---- VAX-31 Ad ...
16m
Investigational New Drug Application Cleared by FDA; Company Expects to Initiate VAX-31 Infant Phase 2 Study by the End of January 2025 -- -- VAX-31 Adult Indication: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback